Lacida, Francisco C.

HRN: 25-95-03  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/18/2024
CO-AMOXICLAV 625MG (TAB)
11/18/2024
11/25/2024
ORAL
625mg/tab
Every 8hours
Empiric
Waiting Final Action 
11/18/2024
CEFUROXIME 500MG (TAB)
11/18/2024
11/25/2024
ORAL
500mg/tab
Every 12hours
Punctured Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: